Skip to main content
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. — Investor Relations & Filings

Ticker · SRPT ISIN · US8036071004 LEI · 549300IKDPIED8J8IG21 US Manufacturing
Open in API
Filings indexed 1,061 across all filing types
Latest filing 2026-06-04 Regulatory Filings
Country US United States of America
Listing US SRPT

About Sarepta Therapeutics, Inc.

https://www.sarepta.com/

Sarepta Therapeutics is a commercial-stage biopharmaceutical company that engineers precision genetic medicines for rare diseases. The company's research and development efforts are centered on RNA-targeted therapeutics and gene therapies, with a primary focus on treating rare neuromuscular and central nervous system disorders. Sarepta aims to accelerate the drug development process from discovery to patient application and is building significant gene therapy manufacturing capabilities to support its mission.

Recent filings

Filing Released Lang Actions
S-8
Regulatory Filings Classification · 92% confidence The document is a Form S-8 registration statement filed with the U.S. SEC to register shares under the company’s 2026 Equity Incentive Plan and Employee Stock Purchase Plan. It is not an annual or interim report, proxy statement, earnings release, or transaction announcement, but a formal securities registration filing. Our taxonomy does not include a specific code for Form S-8, so this falls under the catch-all Regulatory Filings category.
2026-06-04 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a Form 8-K current report disclosing the results of various shareholder votes at the company’s Annual Meeting (election of directors, advisory vote on compensation, approval of equity plans, ratification of auditors). This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-06-04 English
Regulatory Filings 2026
Regulatory Filings
2026-05-13 English
8-K
Regulatory Filings Classification · 92% confidence The document is a Form 8-K current report filed pursuant to Section 13 or 15(d) of the Exchange Act. It contains a press release as an exhibit and includes standard regulatory checkboxes and signature blocks. It does not present actual financial statements itself nor serve as an earnings release or management discussion, but rather is a general regulatory submission. Therefore it falls under ‘Regulatory Filings’ (RNS).
2026-05-06 English
10-Q - Sarepta Therapeutics, Inc. (0000873303) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-06 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.